Our novel transgenic mice, with specific knockdown of EphA3 expression in the TME of implanted syngeneic tumours, showed reduced tumour growth and angiogenesis, and associated defects in stem-like and angiogenic properties in mesenchymal stromal progenitor cells. This evidence concerns the gene EPHA3 and neoplasm.